Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement.
OBJECTIVE
To prospectively assess the incidence of delayed adverse reactions (DARs) in patients undergoing contrast material-enhanced computed tomography (CT) with the low osmolar nonionic contrast agent iohexol and compare with the incidence of DARs in patients undergoing unenhanced CT as control subjects.


METHODS
Institutional review board approval and informed written consent for this prospective study were obtained. The study was HIPAA compliant. Patients undergoing CT for routine indications were enrolled from a random next-available scheduling template by an on-site clinical trials monitor. All subjects received a questionnaire asking them to indicate any DAR occurring later than 1 hour after their examination. Sixteen manifestations were listed and included rash, skin redness, skin swelling, nausea, vomiting, and dizziness, among others. To ensure maximal surveillance, a clinical trials coordinator initiated direct telephone contact for further assessment. Patients suspected of having moderately severe cutaneous reactions were invited to return for a complete dermatologic clinical assessment including skin biopsy, if indicated. Statistical analysis was performed by using a two-sided Wilcoxon-Mann-Whitney test, a logistic regression utilizing a chi(2) test to adjust for sex and age, and a two-sided Fisher exact test.


RESULTS
A total of 539 patients (258 receiving iohexol and 281 not receiving contrast material) were enrolled. DARs were observed in 37 (14.3%) of 258 subjects receiving iohexol and in seven (2.5%) of 281 subjects in the control group (P < .0001, chi(2) test) after adjusting for sex and age. Specific manifestations of DARs that were significantly more frequent at contrast-enhanced CT were skin rash (P = .0311), skin redness (P = .0055), skin swelling (P = .0117), and headache (P = .0246). DARs involving the skin included generalized rashes of the face, neck, chest, back, and extremities and were often associated with swelling, erythema, and pruritus.


CONCLUSIONS
This study substantiates a frequent occurrence of DARs at contrast-enhanced CT compared with that in control subjects. Continued growth in the use of contrast-enhanced CT suggests a need for greater awareness and attention to prevention and management.
Loh
Shaun
S
Department of Diagnostic Radiology, University of California, Davis Medical Center, 4860 Y St, Suite 3100, Sacramento, CA 95817, USA. shaun.loh@ucdmc.ucdavis.edu
Bagheri
Sepideh
S
Katzberg
Richard W
RW
Fung
Maxwell A
MA
Li
Chin-Shang
CS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000453:epidemiology; D015994:Incidence; D007472:Iohexol / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D011795:Surveys and Questionnaires; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D007472:Iohexol
Eur J Radiol. 2007 Feb;61(2):342-50
17101256
Acad Radiol. 1998 Apr;5 Suppl 1:S157-8
9561069
Am Heart J. 2001 Apr;141(4):677-83
11275937
Clin Radiol. 1994 May;49(5):337-40
8013200
Eur Radiol. 2003 Jan;13(1):185-94
12541129
Br J Radiol. 1989 Mar;62(735):260-5
2649192
Eur J Radiol. 1993 Nov;17(3):203-9
8293750
Clin Exp Allergy. 2007 Jul;37(7):989-99
17581192
Radiology. 2006 Jul;240(1):56-64
16720865
Acad Radiol. 1998 Apr;5 Suppl 1:S162-5; discussion S166
9561071
Br J Radiol. 1998 Sep;71(849):910-7
10195003
Nihon Igaku Hoshasen Gakkai Zasshi. 1990 Nov 25;50(11):1359-66
2087395
Eur Radiol. 1996;6(1):9-13
8797943
Br J Radiol. 1986 Jan;59(697):41-4
3947806
J Invasive Cardiol. 2004 Dec;16(12):707-11
15596875
Acad Radiol. 1995 Aug;2(8):683-6
9419625
J Invasive Cardiol. 2003 Mar;15(3):133-8
12612387
Eur Radiol. 1997;7 Suppl 4:S145-8
9204358
Acta Radiol. 1992 Jul;33(4):368-73
1633050